CHABAIDAO Publishes 2025 AGM Agenda: Board Reshuffle, Dual Share Mandates and Supervisory Committee Abolition on Ballot

Bulletin Express
04/29

Sichuan Baicha Baidao Industrial Co., Ltd. (abbreviated as CHABAIDAO) has issued the proxy form and agenda for its 2025 Annual General Meeting, scheduled for 2:00 p.m. on 21 May 2026 at the company’s headquarters in Chengdu.

Key agenda items are divided into ordinary and special resolutions:

1. Routine Reporting • Shareholders will vote on the 2025 Annual Report, the Board of Directors’ Report, the Supervisory Committee’s Report, the Final Accounts Report and the Profit Distribution Plan for 2025. • Re-appointment of the external auditor for the 2026 financial year is proposed.

2. Board Restructuring • Eight directors are nominated for the third board term: Mr. Wang Xiaokun, Mr. Wang Hongxue, Ms. Dai Li and Mr. Chen Keyuan as executive directors; Dr. Chen Da as non-executive director; and Mr. Yeung Chi Tat, Dr. Tang Yong and Ms. Cheng Li as independent non-executive directors. • A corresponding remuneration package for the new board is up for approval.

3. Corporate Governance Updates • Amendments to the Rules of Procedure for Shareholders’ General Meetings and for the Board of Directors are proposed. • A special resolution seeks to abolish the Supervisory Committee, accompanied by amendments to the Articles of Association.

4. Capital Management Authorities • Shareholders will consider granting a general mandate to the board to issue additional shares. • A parallel mandate would authorize the company to repurchase its own shares within regulatory limits.

Shareholders of CHABAIDAO’s H-shares who wish to vote by proxy must lodge the completed form with Computershare Hong Kong Investor Services Limited no less than 24 hours before the meeting. Personal attendance remains an option, subject to presentation of valid identification.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10